Risk Factors for Acute Kidney Injury in Critically Ill Patients With Acute-on-Chronic Liver Failure
1 other identifier
observational
200
1 country
1
Brief Summary
Acute kidney injury (AKI) is one of the most important factors associated with increased mortality in patients with acute-on-chronic liver failure (AoCLF). Early identification and treatment of this subgroup of patients may improve survival and decrease ICU length of stay. As kidney ischemia is one of the main mechanisms responsible for AKI in AoCLF, an increase in urinary to arterial partial pressure of oxygen may help in the early diagnosis of renal failure. For this arterial and urinary oxygen pressure will be measured at ICU admission, on day 1 and day 3 of ICU stay. Diagnosis of AKI within the first 28 days after ICU admission will be recorded
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2020
CompletedFirst Posted
Study publicly available on registry
August 25, 2020
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 15, 2023
February 1, 2023
3.6 years
August 21, 2020
February 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
AKI
incidence (%) of AKI in patients with AoCLF as defined by Acute Kidney Injury Network guidelines
28 days after ICU admission
Secondary Outcomes (2)
arterial to urinary oxygen gradient
ICU admission, ICU day 1 and ICU dy 3
mortality
28-days
Eligibility Criteria
All consecutive patients admitted to a general ICU for ACLF who fall into the inclusion and exclusion criteria. Standard treatment will be applied to all patients and no supplemental intervention is required for the present study.
You may qualify if:
- \- patients admitted to the ICU for acute-on-chronic liver failure
You may not qualify if:
- pre-existing renal disease
- urine output\<200 mL/day
- death within the first 24 hours after ICU admission
- emergency liver transplantation within the follow-up period (28 days)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Popescu Mihai
Bucharest, 022328, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dana Tomescu, Prof
Fundeni Clinical Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
August 21, 2020
First Posted
August 25, 2020
Study Start
February 1, 2021
Primary Completion
September 1, 2024
Study Completion
December 31, 2024
Last Updated
February 15, 2023
Record last verified: 2023-02